title: The effect of methamphetamine on the release of acetylcholine in the rat striatum.
abstract: We examined the effect of methamphetamine on the release of acetylcholine in the striatum of freely moving rats, using an in vivo microdialysis method. The basal level of acetylcholine was 3.67+/-0.47 pmol/30 microl per 15 min in the presence of neostigmine (10 microM). Tetrodotoxin (1 microM), a selective blocker of voltage-dependent Na+ channels, markedly inhibited the release of acetylcholine in the striatal perfusates. Apomorphine (1.0 mg/kg, i.p.), a dopamine receptor agonist, also significantly attenuated acetylcholine release. Methamphetamine (0.1 and 0.5 mg/kg, i.p.) did not immediately affect acetylcholine release in the striatum, but a dose of 1.0 mg/kg (i.p.) induced an increase of acetylcholine release in the striatum at 15-60 min. Striatal infusion of methamphetamine (5 and 10 microM) did not influence acetylcholine release. The increase following intraperitoneal administration of methamphetamine was slightly diminished by haloperidol (0.5 mg/kg). After microinjection of the neurotoxin, 6-hydroxydopamine (6 microg/3 microl), in the substantia nigra 7 days before, the increase of acetylcholine induced by the administration of methamphetamine (1.0 mg/kg) was slightly attenuated, whereas the administration of reserpine (2 mg/kg, i.p.) 24 h before, combined with alpha-methyl-p-tyrosine (300 mg/kg, i.p.) 2.5 h before, completely blocked the increase in release of acetylcholine. These findings suggest that methamphetamine exerts an excitatory influence on striatal acetylcholine release in freely moving rats, and that this excitatory effect involves the dopaminergic system and the catecholaminergic system.
authors.affiliation: Department of Neuroscience, Showa College of Pharmaceutical Sciences, Machida, Tokyo, Japan. taguchi@ac.shoyaku.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Taguchi
authors.forename: J
authors.initials: J
authors.lastname: Atobe
authors.forename: M
authors.initials: M
authors.lastname: Kato
authors.forename: T
authors.initials: T
authors.lastname: Chuma
authors.forename: T
authors.initials: T
authors.lastname: Chikuma
authors.forename: T
authors.initials: T
authors.lastname: Shigenaga
authors.forename: T
authors.initials: T
authors.lastname: Miyatake
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D018663:Adrenergic Agents / Q000494:pharmacology; D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D017551:Microdialysis; D016627:Oxidopamine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012110:Reserpine / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D019805:alpha-Methyltyrosine / Q000494:pharmacology
chemical_list: D018663:Adrenergic Agents; D018759:Adrenergic Uptake Inhibitors; D018491:Dopamine Agonists; D018765:Dopamine Uptake Inhibitors; D004791:Enzyme Inhibitors; D013779:Tetrodotoxin; D008694:Methamphetamine; D019805:alpha-Methyltyrosine; D012110:Reserpine; D016627:Oxidopamine; D001058:Apomorphine; D000109:Acetylcholine